FDA reviewing heart risks of Glaxo diabetes pill W
Post# of 28526
Posted On: 04/13/2013 8:10:44 AM
FDA reviewing heart risks of Glaxo diabetes pill WASHINGTON (AP) — The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster drug Avandia, which was severely restricted in 2010 due to concerns about its impact on the heart.
(0)
(0)
test
Scroll down for more posts ▼